ID   HA11_MOUSE              Reviewed;         362 AA.
AC   P01899;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 2.
DT   22-JUL-2015, entry version 153.
DE   RecName: Full=H-2 class I histocompatibility antigen, D-B alpha chain;
DE            Short=H-2D(B);
DE   Flags: Precursor;
GN   Name=H2-D1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=C3H;
RX   PubMed=3680952;
RA   Watts S., Vogel J.M., Harriman W.D., Itoh T., Stauss H.J.,
RA   Goodenow R.S.;
RT   "DNA sequence analysis of the C3H H-2Kk and H-2Dk loci. Evolutionary
RT   relationships to H-2 genes from four other mouse strains.";
RL   J. Immunol. 139:3878-3885(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=NOD/LT;
RA   Girgis K.R., Capra D.J., Stroynowski I.;
RL   Submitted (MAY-1995) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/10;
RX   PubMed=9869916;
RA   Wang M., Stepkowski S.M., Hebert J.S., Tian L., Yu J., Kahan B.D.;
RT   "Nucleotide sequences of three H-2K and three H-2D complementary DNA
RT   clones coding mouse class I MHC heavy chain proteins.";
RL   Ann. Transplant. 1:26-31(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 105-362.
RX   PubMed=7118211; DOI=10.1007/BF00364437;
RA   Reyes A.A., Schold M., Wallace R.B.;
RT   "The complete amino acid sequence of the murine transplantation
RT   antigen H-2Db as deduced by molecular cloning.";
RL   Immunogenetics 16:1-9(1982).
RN   [5]
RP   PROTEIN SEQUENCE OF 25-122.
RX   PubMed=7225204;
RA   Maloy W.L., Nathenson S.G., Coligan J.E.;
RT   "Primary structure of murine major histocompatibility complex
RT   alloantigens. Amino acid sequence of the NH2-terminal ninety-eight
RT   residues of the H-2Db glycoprotein.";
RL   J. Biol. Chem. 256:2863-2872(1981).
RN   [6]
RP   PROTEIN SEQUENCE OF 253-308 AND 332-358.
RX   PubMed=7118212; DOI=10.1007/BF00364438;
RA   Maloy W.L., Coligan J.E.;
RT   "Primary structure of the H-2Db alloantigen. II. Additional amino acid
RT   sequence information, localization of a third site of glycosylation
RT   and evidence for K and D region specific sequences.";
RL   Immunogenetics 16:11-22(1982).
RN   [7]
RP   GLYCOSYLATION AT ASN-110 AND ASN-280.
RX   PubMed=3980466;
RA   Swiedler S.J., Freed J.H., Tarentino A.L., Plummer T.H. Jr.,
RA   Hart G.W.;
RT   "Oligosaccharide microheterogeneity of the murine major
RT   histocompatibility antigens. Reproducible site-specific patterns of
RT   sialylation and branching in asparagine-linked oligosaccharides.";
RL   J. Biol. Chem. 260:4046-4054(1985).
RN   [8]
RP   UBIQUITINATION, INTERACTION WITH MURID HERPESVIRUS 4 K3, AND
RP   MUTAGENESIS OF LYS-55; LYS-92; LYS-155; LYS-170; LYS-197; LYS-210;
RP   LYS-220; LYS-267; LYS-277; LYS-332; THR-337; LYS-340; 350-SER--SER-356
RP   AND 360-CYS-LYS-361.
RX   PubMed=17502423; DOI=10.1083/jcb.200611063;
RA   Wang X., Herr R.A., Chua W.J., Lybarger L., Wiertz E.J., Hansen T.H.;
RT   "Ubiquitination of serine, threonine, or lysine residues on the
RT   cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3.";
RL   J. Cell Biol. 177:613-624(2007).
RN   [9]
RP   UBIQUITINATION AT SER-353, INTERACTION WITH MURID HERPESVIRUS 4 K3,
RP   AND MUTAGENESIS OF LYS-332; THR-337; LYS-340; 350-SER--SER-352;
RP   SER-356 AND 360-CYS-LYS-361.
RX   PubMed=19951915; DOI=10.1083/jcb.200908036;
RA   Wang X., Herr R.A., Rabelink M., Hoeben R.C., Wiertz E.J.,
RA   Hansen T.H.;
RT   "Ube2j2 ubiquitinates hydroxylated amino acids on ER-associated
RT   degradation substrates.";
RL   J. Cell Biol. 187:655-668(2009).
RN   [10]
RP   UBIQUITINATION, INTERACTION WITH MURID HERPESVIRUS 4 K3, AND
RP   MUTAGENESIS OF LYS-332; THR-337; LYS-340; 350-SER--SER-352; SER-356
RP   AND 360-CYS-LYS-361.
RX   PubMed=19531064; DOI=10.1111/j.1600-0854.2009.00946.x;
RA   Herr R.A., Harris J., Fang S., Wang X., Hansen T.H.;
RT   "Role of the RING-CH domain of viral ligase mK3 in ubiquitination of
RT   non-lysine and lysine MHC I residues.";
RL   Traffic 10:1301-1317(2009).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 25-296.
RX   PubMed=7506996; DOI=10.1016/0092-8674(94)90171-6;
RA   Young A.C.M., Zhang W., Sacchettini J.C., Nathenson S.G.;
RT   "The three-dimensional structure of H-2Db at 2.4-A resolution:
RT   implications for antigen-determinant selection.";
RL   Cell 76:39-50(1994).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) OF 24-304, AND DISULFIDE BONDS.
RX   PubMed=10993729; DOI=10.1006/jmbi.2000.4501;
RA   Tissot A.C., Ciatto C., Mittl P.R., Grutter M.G., Pluckthun A.;
RT   "Viral escape at the molecular level explained by quantitative T-cell
RT   receptor/peptide/MHC interactions and the crystal structure of a
RT   peptide/MHC complex.";
RL   J. Mol. Biol. 302:873-885(2000).
CC   -!- FUNCTION: Involved in the presentation of foreign antigens to the
CC       immune system.
CC   -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2-
CC       microglobulin). Interacts with murid herpesvirus 4 protein K3
CC       (mK3). {ECO:0000269|PubMed:17502423, ECO:0000269|PubMed:19531064,
CC       ECO:0000269|PubMed:19951915}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Polyubiquitinated in case of infection by murid herpesvirus
CC       4, by the viral E3 ligase K3 (mK3). This modification causes the
CC       protein to be targeted for rapid degradation by the endoplasmic
CC       reticulum-associated degradation (ERAD) system. Ubiquitination
CC       occurs on lysine, as well as serine and threonine residues present
CC       in the cytoplasmic tail. Serine and threonine residues are subject
CC       to ubiquitination via ester bonds instead of the usual isopeptide
CC       linkage. {ECO:0000269|PubMed:17502423,
CC       ECO:0000269|PubMed:19531064, ECO:0000269|PubMed:19951915}.
CC   -!- SIMILARITY: Belongs to the MHC class I family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA39580.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M18523; AAA53200.1; -; Genomic_DNA.
DR   EMBL; L36068; AAA89206.1; -; mRNA.
DR   EMBL; U47325; AAB17603.1; -; mRNA.
DR   EMBL; K00129; AAA39580.1; ALT_INIT; mRNA.
DR   CCDS; CCDS57074.1; -.
DR   PIR; B60854; B60854.
DR   PIR; I56002; HLMSDB.
DR   RefSeq; NP_034510.3; NM_010380.3.
DR   UniGene; Mm.439675; -.
DR   PDB; 1BZ9; X-ray; 2.80 A; A=26-299.
DR   PDB; 1CE6; X-ray; 2.90 A; A=25-298.
DR   PDB; 1FFN; X-ray; 2.70 A; A/D=26-298.
DR   PDB; 1FFO; X-ray; 2.65 A; A/D=26-298.
DR   PDB; 1FFP; X-ray; 2.60 A; A/D=26-298.
DR   PDB; 1FG2; X-ray; 2.75 A; A/D/G/J=25-304.
DR   PDB; 1HOC; X-ray; 2.40 A; A=25-296.
DR   PDB; 1INQ; X-ray; 2.20 A; A=25-299.
DR   PDB; 1JPF; X-ray; 2.18 A; A=25-304.
DR   PDB; 1JPG; X-ray; 2.20 A; A=25-304.
DR   PDB; 1JUF; X-ray; 2.00 A; A=25-299.
DR   PDB; 1N3N; X-ray; 3.00 A; A/C/E/G=25-304.
DR   PDB; 1N5A; X-ray; 2.85 A; A/D/G/J=25-300.
DR   PDB; 1QLF; X-ray; 2.65 A; A=25-300.
DR   PDB; 1S7U; X-ray; 2.20 A; A/D/G/J=25-362.
DR   PDB; 1S7V; X-ray; 2.20 A; A/D=25-362.
DR   PDB; 1S7W; X-ray; 2.40 A; A/D/G/J=25-362.
DR   PDB; 1S7X; X-ray; 2.41 A; A/D/G/J=25-362.
DR   PDB; 1WBX; X-ray; 1.90 A; A=25-300.
DR   PDB; 1WBY; X-ray; 2.30 A; A=25-300.
DR   PDB; 1YN6; X-ray; 2.20 A; A=26-298.
DR   PDB; 1YN7; X-ray; 2.20 A; A=26-298.
DR   PDB; 1ZHB; X-ray; 2.70 A; A/D/G/J=25-300.
DR   PDB; 2CII; X-ray; 2.55 A; A=25-299.
DR   PDB; 2F74; X-ray; 2.70 A; A/D=25-300.
DR   PDB; 2VE6; X-ray; 2.65 A; A/D/G/J=25-301.
DR   PDB; 2ZOK; X-ray; 2.10 A; A/C/E/G=25-299.
DR   PDB; 2ZOL; X-ray; 2.70 A; A/C=25-299.
DR   PDB; 3BUY; X-ray; 2.60 A; A=26-300.
DR   PDB; 3CC5; X-ray; 1.91 A; A/D=25-300.
DR   PDB; 3CCH; X-ray; 2.60 A; A/D/G/J=25-300.
DR   PDB; 3CH1; X-ray; 2.30 A; A/D/G/J=25-300.
DR   PDB; 3CPL; X-ray; 2.50 A; A/C=25-299.
DR   PDB; 3FTG; X-ray; 2.60 A; A=25-304.
DR   PDB; 3L3H; X-ray; 2.70 A; A=26-300.
DR   PDB; 3PQY; X-ray; 3.19 A; A/F/K/P=26-300.
DR   PDB; 3QUK; X-ray; 2.41 A; A/D=25-362.
DR   PDB; 3QUL; X-ray; 2.00 A; A/D/G/J=25-362.
DR   PDB; 3TBS; X-ray; 2.49 A; A/D=25-362.
DR   PDB; 3TBT; X-ray; 2.30 A; A/D/G/J=25-362.
DR   PDB; 3TBV; X-ray; 2.10 A; A/C/E/G=25-362.
DR   PDB; 3TBW; X-ray; 2.15 A; A/C/E/G=25-362.
DR   PDB; 3TBY; X-ray; 2.50 A; A/D/G/J=25-362.
DR   PDB; 3WS3; X-ray; 2.34 A; A/C=26-298.
DR   PDB; 3WS6; X-ray; 1.98 A; A/B=26-300.
DR   PDB; 4HUU; X-ray; 2.00 A; A/D=25-304.
DR   PDB; 4HUV; X-ray; 2.50 A; A/D=25-304.
DR   PDB; 4HUW; X-ray; 3.16 A; A/C/E/G=25-304.
DR   PDB; 4HUX; X-ray; 2.20 A; A=25-304.
DR   PDB; 4HV8; X-ray; 2.00 A; A/C=25-304.
DR   PDB; 4IHO; X-ray; 2.80 A; A/D=25-300.
DR   PDB; 4L8B; X-ray; 2.20 A; A=25-304.
DR   PDB; 4L8C; X-ray; 2.80 A; A/C/E/G=25-304.
DR   PDB; 4L8D; X-ray; 1.90 A; A/C=25-304.
DR   PDB; 4NSK; X-ray; 2.60 A; A=25-300.
DR   PDB; 4PG2; X-ray; 2.80 A; A=25-299.
DR   PDBsum; 1BZ9; -.
DR   PDBsum; 1CE6; -.
DR   PDBsum; 1FFN; -.
DR   PDBsum; 1FFO; -.
DR   PDBsum; 1FFP; -.
DR   PDBsum; 1FG2; -.
DR   PDBsum; 1HOC; -.
DR   PDBsum; 1INQ; -.
DR   PDBsum; 1JPF; -.
DR   PDBsum; 1JPG; -.
DR   PDBsum; 1JUF; -.
DR   PDBsum; 1N3N; -.
DR   PDBsum; 1N5A; -.
DR   PDBsum; 1QLF; -.
DR   PDBsum; 1S7U; -.
DR   PDBsum; 1S7V; -.
DR   PDBsum; 1S7W; -.
DR   PDBsum; 1S7X; -.
DR   PDBsum; 1WBX; -.
DR   PDBsum; 1WBY; -.
DR   PDBsum; 1YN6; -.
DR   PDBsum; 1YN7; -.
DR   PDBsum; 1ZHB; -.
DR   PDBsum; 2CII; -.
DR   PDBsum; 2F74; -.
DR   PDBsum; 2VE6; -.
DR   PDBsum; 2ZOK; -.
DR   PDBsum; 2ZOL; -.
DR   PDBsum; 3BUY; -.
DR   PDBsum; 3CC5; -.
DR   PDBsum; 3CCH; -.
DR   PDBsum; 3CH1; -.
DR   PDBsum; 3CPL; -.
DR   PDBsum; 3FTG; -.
DR   PDBsum; 3L3H; -.
DR   PDBsum; 3PQY; -.
DR   PDBsum; 3QUK; -.
DR   PDBsum; 3QUL; -.
DR   PDBsum; 3TBS; -.
DR   PDBsum; 3TBT; -.
DR   PDBsum; 3TBV; -.
DR   PDBsum; 3TBW; -.
DR   PDBsum; 3TBY; -.
DR   PDBsum; 3WS3; -.
DR   PDBsum; 3WS6; -.
DR   PDBsum; 4HUU; -.
DR   PDBsum; 4HUV; -.
DR   PDBsum; 4HUW; -.
DR   PDBsum; 4HUX; -.
DR   PDBsum; 4HV8; -.
DR   PDBsum; 4IHO; -.
DR   PDBsum; 4L8B; -.
DR   PDBsum; 4L8C; -.
DR   PDBsum; 4L8D; -.
DR   PDBsum; 4NSK; -.
DR   PDBsum; 4PG2; -.
DR   ProteinModelPortal; P01899; -.
DR   SMR; P01899; 25-301.
DR   DIP; DIP-6121N; -.
DR   IntAct; P01899; 2.
DR   MINT; MINT-85762; -.
DR   STRING; 10090.ENSMUSP00000134570; -.
DR   MaxQB; P01899; -.
DR   PaxDb; P01899; -.
DR   PRIDE; P01899; -.
DR   Ensembl; ENSMUST00000172785; ENSMUSP00000134570; ENSMUSG00000073411.
DR   GeneID; 14964; -.
DR   KEGG; mmu:14964; -.
DR   UCSC; uc008chg.1; mouse.
DR   CTD; 14964; -.
DR   MGI; MGI:95896; H2-D1.
DR   eggNOG; NOG42056; -.
DR   GeneTree; ENSGT00760000118960; -.
DR   HOVERGEN; HBG016709; -.
DR   KO; K06751; -.
DR   OMA; QMSAHID; -.
DR   OrthoDB; EOG7JT6WQ; -.
DR   PhylomeDB; P01899; -.
DR   TreeFam; TF336617; -.
DR   Reactome; REACT_300990; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; REACT_308964; ER-Phagosome pathway.
DR   Reactome; REACT_339401; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   Reactome; REACT_341075; ER-Phagosome pathway.
DR   Reactome; REACT_342269; Endosomal/Vacuolar pathway.
DR   Reactome; REACT_349056; Interferon gamma signaling.
DR   EvolutionaryTrace; P01899; -.
DR   NextBio; 287322; -.
DR   Proteomes; UP000000589; Chromosome 17.
DR   Bgee; P01899; -.
DR   CleanEx; MM_H2-D1; -.
DR   ExpressionAtlas; P01899; baseline and differential.
DR   Genevisible; P01899; MM.
DR   GO; GO:0009986; C:cell surface; ISO:MGI.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:MGI.
DR   GO; GO:0070971; C:endoplasmic reticulum exit site; ISO:MGI.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0070062; C:extracellular exosome; ISO:MGI.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:MGI.
DR   GO; GO:0005797; C:Golgi medial cisterna; ISO:MGI.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; ISO:MGI.
DR   GO; GO:0042612; C:MHC class I protein complex; ISO:MGI.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0030881; F:beta-2-microglobulin binding; ISO:MGI.
DR   GO; GO:0042605; F:peptide antigen binding; ISO:MGI.
DR   GO; GO:0044822; F:poly(A) RNA binding; ISO:MGI.
DR   GO; GO:0005102; F:receptor binding; ISO:MGI.
DR   GO; GO:0042608; F:T cell receptor binding; ISO:MGI.
DR   GO; GO:0046977; F:TAP binding; ISO:MGI.
DR   GO; GO:0002485; P:antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent; IDA:MGI.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IDA:MGI.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.30.500.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR027648; MHC_I_a.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   InterPro; IPR010579; MHC_I_a_C.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   Pfam; PF06623; MHC_I_C; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Immunity; Membrane; MHC I;
KW   Phosphoprotein; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     24       {ECO:0000269|PubMed:7225204}.
FT   CHAIN        25    362       H-2 class I histocompatibility antigen,
FT                                D-B alpha chain.
FT                                /FTId=PRO_0000018923.
FT   TOPO_DOM     25    309       Extracellular. {ECO:0000255}.
FT   TRANSMEM    310    331       Helical. {ECO:0000255}.
FT   TOPO_DOM    332    362       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      209    297       Ig-like C1-type.
FT   REGION       25    114       Alpha-1.
FT   REGION      115    206       Alpha-2.
FT   REGION      207    298       Alpha-3.
FT   REGION      299    309       Connecting peptide.
FT   MOD_RES     353    353       Phosphoserine; alternate.
FT                                {ECO:0000250|UniProtKB:P01900}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P01900}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:3980466,
FT                                ECO:0000269|PubMed:7118212}.
FT   CARBOHYD    200    200       N-linked (GlcNAc...). {ECO:0000305}.
FT   CARBOHYD    280    280       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:3980466}.
FT   DISULFID    125    188       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:10993729}.
FT   DISULFID    227    283       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:10993729}.
FT   CROSSLNK    353    353       Glycyl serine ester (Ser-Gly) (interchain
FT                                with G-Cter in ubiquitin); alternate.
FT                                {ECO:0000305|PubMed:19951915}.
FT   MUTAGEN      55     55       K->R: In K-less, no effect on
FT                                ubiquitination; when associated with R-
FT                                92, R-155, R-170, R-197, R-210, R-220, R-
FT                                267 and R-277.
FT                                {ECO:0000269|PubMed:17502423}.
FT   MUTAGEN      92     92       K->R: In K-less, no effect on
FT                                ubiquitination; when associated with R-
FT                                55, R-155, R-170, R-197, R-210, R-220, R-
FT                                267 and R-277.
FT                                {ECO:0000269|PubMed:17502423}.
FT   MUTAGEN     155    155       K->R: In K-less, no effect on
FT                                ubiquitination; when associated with R-
FT                                55, R-92, R-170, R-197, R-210, R-220, R-
FT                                267 and R-277.
FT                                {ECO:0000269|PubMed:17502423}.
FT   MUTAGEN     170    170       K->R: In K-less, no effect on
FT                                ubiquitination; when associated with R-
FT                                55, R-92, R-155, R-197, R-210, R-220, R-
FT                                267 and R-277.
FT                                {ECO:0000269|PubMed:17502423}.
FT   MUTAGEN     197    197       K->R: In K-less, no effect on
FT                                ubiquitination; when associated with R-
FT                                55, R-92, R-155, R-170, R-210, R-220, R-
FT                                267 and R-277.
FT                                {ECO:0000269|PubMed:17502423}.
FT   MUTAGEN     210    210       K->R: In K-less, no effect on
FT                                ubiquitination; when associated with R-
FT                                55, R-92, R-155, R-170, R-197, R-220, R-
FT                                267 and R-277.
FT                                {ECO:0000269|PubMed:17502423}.
FT   MUTAGEN     220    220       K->R: In K-less, no effect on
FT                                ubiquitination; when associated with R-
FT                                55, R-92, R-155, R-170, R-197, R-210, R-
FT                                267 and R-277.
FT                                {ECO:0000269|PubMed:17502423}.
FT   MUTAGEN     267    267       K->R: In K-less, no effect on
FT                                ubiquitination; when associated with R-
FT                                55, R-92, R-155, R-170, R-197, R-210, R-
FT                                220 and R-277.
FT                                {ECO:0000269|PubMed:17502423}.
FT   MUTAGEN     277    277       K->R: In K-less, no effect on
FT                                ubiquitination; when associated with R-
FT                                55, R-92, R-155, R-170, R-197, R-210, R-
FT                                220 and R-267.
FT                                {ECO:0000269|PubMed:17502423}.
FT   MUTAGEN     332    332       K->R: In Ld KCST-less, strongly impairs
FT                                ubiquitination; when associated with I-
FT                                337; R-340; 350-A--A-356 and 360-R-R-361.
FT                                In Ld tail 1S, restores ubiquitination;
FT                                when associated I-337; R-340; 350-A--A-
FT                                352; A-356 and 360-R-R-361.
FT                                {ECO:0000269|PubMed:17502423,
FT                                ECO:0000269|PubMed:19531064,
FT                                ECO:0000269|PubMed:19951915}.
FT   MUTAGEN     337    337       T->I: In Ld KCST-less, strongly impairs
FT                                ubiquitination; when associated with R-
FT                                332; R-340; 350-A--A-356 and 360-R-R-361.
FT                                In Ld tail 1S, restores ubiquitination;
FT                                when associated R-332; R-340; 350-A--A-
FT                                352; A-356 and 360-R-R-361.
FT                                {ECO:0000269|PubMed:17502423,
FT                                ECO:0000269|PubMed:19531064,
FT                                ECO:0000269|PubMed:19951915}.
FT   MUTAGEN     340    340       K->R: In Ld KCST-less, strongly impairs
FT                                ubiquitination; when associated with R-
FT                                332; I-337; 350-A--A-356 and 360-R-R-361.
FT                                In Ld tail 1S, restores ubiquitination;
FT                                when associated R-332; I-337; 350-A--A-
FT                                352; A-356 and 360-R-R-361.
FT                                {ECO:0000269|PubMed:17502423,
FT                                ECO:0000269|PubMed:19531064,
FT                                ECO:0000269|PubMed:19951915}.
FT   MUTAGEN     350    356       SQSSEMS->AQGAEMA: In Ld KCST-less,
FT                                strongly impairs ubiquitination; when
FT                                associated with R-332; I-337 and 360-R-R-
FT                                361. {ECO:0000269|PubMed:17502423}.
FT   MUTAGEN     350    352       SQS->AQG: In Ld tail 1S, restores
FT                                ubiquitination; when associated R-332; I-
FT                                337; R-340; A-356 and 360-R-R-361.
FT                                {ECO:0000269|PubMed:19531064,
FT                                ECO:0000269|PubMed:19951915}.
FT   MUTAGEN     356    356       S->A: In Ld tail 1S, restores
FT                                ubiquitination; when associated R-332; I-
FT                                337; R-340 and A-356.
FT                                {ECO:0000269|PubMed:19531064,
FT                                ECO:0000269|PubMed:19951915}.
FT   MUTAGEN     360    361       CK->RR: In Ld KCST-less, strongly impairs
FT                                ubiquitination; when associated with R-
FT                                332; I-337; R-340 and 350-A--A-356. In Ld
FT                                tail 1S, restores ubiquitination; when
FT                                associated R-332; I-337; R-340; 350-A--A-
FT                                352; A-356 and 360-R-R-361.
FT                                {ECO:0000269|PubMed:17502423,
FT                                ECO:0000269|PubMed:19531064,
FT                                ECO:0000269|PubMed:19951915}.
FT   STRAND       27     36       {ECO:0000244|PDB:1WBX}.
FT   STRAND       39     41       {ECO:0000244|PDB:1JUF}.
FT   STRAND       45     52       {ECO:0000244|PDB:1WBX}.
FT   STRAND       55     61       {ECO:0000244|PDB:1WBX}.
FT   STRAND       64     66       {ECO:0000244|PDB:1WBX}.
FT   STRAND       70     73       {ECO:0000244|PDB:3CC5}.
FT   HELIX        74     78       {ECO:0000244|PDB:1WBX}.
FT   HELIX        81    108       {ECO:0000244|PDB:1WBX}.
FT   STRAND      113    115       {ECO:0000244|PDB:1WBX}.
FT   STRAND      118    127       {ECO:0000244|PDB:1WBX}.
FT   STRAND      131    142       {ECO:0000244|PDB:1WBX}.
FT   STRAND      145    150       {ECO:0000244|PDB:1WBX}.
FT   STRAND      157    159       {ECO:0000244|PDB:1WBX}.
FT   HELIX       162    174       {ECO:0000244|PDB:1WBX}.
FT   HELIX       177    185       {ECO:0000244|PDB:1WBX}.
FT   HELIX       187    198       {ECO:0000244|PDB:1WBX}.
FT   HELIX       200    203       {ECO:0000244|PDB:1WBX}.
FT   STRAND      210    219       {ECO:0000244|PDB:1WBX}.
FT   STRAND      222    235       {ECO:0000244|PDB:1WBX}.
FT   STRAND      238    243       {ECO:0000244|PDB:1WBX}.
FT   STRAND      246    248       {ECO:0000244|PDB:3CC5}.
FT   STRAND      250    254       {ECO:0000244|PDB:4L8D}.
FT   STRAND      261    263       {ECO:0000244|PDB:1WBX}.
FT   STRAND      265    274       {ECO:0000244|PDB:1WBX}.
FT   HELIX       278    280       {ECO:0000244|PDB:1WBX}.
FT   STRAND      281    286       {ECO:0000244|PDB:1WBX}.
FT   STRAND      290    292       {ECO:0000244|PDB:4L8D}.
FT   STRAND      294    296       {ECO:0000244|PDB:1WBX}.
SQ   SEQUENCE   362 AA;  40836 MW;  6EE6AEF97263FA71 CRC64;
     MGAMAPRTLL LLLAAALAPT QTRAGPHSMR YFETAVSRPG LEEPRYISVG YVDNKEFVRF
     DSDAENPRYE PRAPWMEQEG PEYWERETQK AKGQEQWFRV SLRNLLGYYN QSAGGSHTLQ
     QMSGCDLGSD WRLLRGYLQF AYEGRDYIAL NEDLKTWTAA DMAAQITRRK WEQSGAAEHY
     KAYLEGECVE WLHRYLKNGN ATLLRTDSPK AHVTHHPRSK GEVTLRCWAL GFYPADITLT
     WQLNGEELTQ DMELVETRPA GDGTFQKWAS VVVPLGKEQN YTCRVYHEGL PEPLTLRWEP
     PPSTDSYMVI VAVLGVLGAM AIIGAVVAFV MKRRRNTGGK GGDYALAPGS QSSEMSLRDC
     KA
//
